CSF homovanillic acid in schizotypal personality disorder

  • Larry J. Siever
  • , Farooq Amin
  • , Emil F. Coccaro
  • , Robert Trestman
  • , Jeremy Silverman
  • , Thomas B. Horvath
  • , Theresa R. Mahon
  • , Peter Knott
  • , Larry Altstiel
  • , Michael Davidson
  • , Kenneth L. Davis

Research output: Contribution to journalArticlepeer-review

Abstract

CSF concentrations of homovanillic acid (HVA) were measured in 10 patients with schizotypal personality disorder and 14 patients with other personality disorders. The patients with schizotypal personality disorder had higher CSF HVA concentrations than the patients with other personality disorders. Furthermore, the psychotic-like schizotypal symptoms correlated positively with the CSF HVA concentrations. These results suggest a central dopaminergic dysfunction associated with the psychotic-like symptoms of schizotypal personality disorder.

Original languageEnglish
Pages (from-to)149-151
Number of pages3
JournalAmerican Journal of Psychiatry
Volume150
Issue number1
DOIs
Publication statusPublished - 1993
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'CSF homovanillic acid in schizotypal personality disorder'. Together they form a unique fingerprint.

Cite this